This grant, offered by this department, supports research partnerships between academic and industrial investigators. Its primary purpose is to accelerate the translation of preclinical or clinical in vivo imaging systems and methods to solve targeted cancer problems. This includes single or multi-modality imaging, spectroscopy, image-guided and drug delivery systems, and image analysis. Funding can be used to enhance, adapt, optimize, validate, and translate current or next-generation imaging capabilities not yet broadly employed. The program emphasizes innovative translational plans to deliver new tools for preclinical or clinical use. It supports clinical trials focused on optimizing and validating the performance of imaging systems, devices, or methods, ensuring a coherent strategy to advance cancer investigations.
Opportunity ID: 229373
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-13-169 |
Funding Opportunity Title: | Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 05, 2013 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2016 |
Current Closing Date for Applications: | May 07, 2016 |
Archive Date: | Jun 07, 2016 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Special district governments State governments For profit organizations other than small businesses Small businesses County governments Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators to accelerate the translation of either preclinical or clinical in vivo imaging systems and/or methods that are designed to solve a targeted cancer problem. The proposed imaging system/methods may include single or multi-modality in vivo imaging and spectroscopy systems, image-guided and drug delivery systems, image analysis, and related research resources. This FOA may also include, as a secondary goal, support for other laboratory imaging or reference methods as required to validate the performance of the proposed in vivo imaging system and/or methods. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate the following examples, among others: (a) current commercially supported imaging systems/methods, (b) next-generation imaging systems/methods, (c) quality assurance and quality control methods, (d) validation and correlation studies, (e) quantitative imaging methods, and (f) related research resources. Because appropriate applications must be translational in scope, this FOA defines innovation as a coherent translational plan to deliver emerging or new capabilities for preclinical or clinical use that are not yet broadly employed in preclinical or clinical settings. The partnerships on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their proposed imaging system/methods to solve a targeted cancer problem. This FOA will support clinical trials that emphasize optimization and validation of the performance of imaging systems, including devices, agents and/or methods. This FOA will not support commercial production, or basic research projects that do not emphasize translational development and optimization of the methods for a targeted cancer problem. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-169.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00172550 | May 05, 2013 | Sep 24, 2013 | View | |
FORMS-C | Use for due dates after 9/24/2013 | PKG00180658 | Sep 08, 2013 | May 07, 2016 | View |
Package 1
Mandatory forms
229373 RR_SF424_1_2-1.2.pdf
229373 PerformanceSite_1_4-1.4.pdf
229373 RR_OtherProjectInfo_1_3-1.3.pdf
229373 RR_KeyPersonExpanded_1_2-1.2.pdf
229373 PHS398_CoverPageSupplement_1_4-1.4.pdf
229373 PHS398_ResearchPlan_1_3-1.3.pdf
229373 PHS398_Checklist_1_3-1.3.pdf
Optional forms
229373 RR_SubawardBudget30-1.2.pdf
229373 PHS398_ModularBudget_1_2-1.2.pdf
229373 RR_Budget-1.1.pdf
229373 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
229373 RR_SF424_2_0-2.0.pdf
229373 PHS398_ResearchPlan_2_0-2.0.pdf
229373 PHS398_CoverPageSupplement_2_0-2.0.pdf
229373 RR_KeyPersonExpanded_2_0-2.0.pdf
229373 RR_OtherProjectInfo_1_3-1.3.pdf
229373 PerformanceSite_2_0-2.0.pdf
Optional forms
229373 RR_SubawardBudget30_1_3-1.3.pdf
229373 PlannedReport-1.0.pdf
229373 PHS398_CumulativeInclusionReport-1.0.pdf
229373 PHS398_ModularBudget_1_2-1.2.pdf
229373 RR_Budget_1_3-1.3.pdf